Research

The technology supporting the SEDMax^TM Units is based on sound scientific principle, well established and documented in worldwide literature (over 400 scientific publications).  Positive results from clinical trials and excellent product design, combine to offer the promise of a major new treatment modality for pain management.
Bio-Enhancement has cooperated with several researchers who conducted studies using the SEDMax^TM technology to treat back pain.  These trials began at the Rusk Institute, New York Medical Center, with Parkinson patients and with patients who suffer from back pain.  There were two additional studies done in an Orthopedic practice and rehabilition center both located in Maryland.  The anecdotal reports from the studies were that patients experienced systemic effects while using the SEDMax^TM technology.  These effects included: flushing, a sense of warmth and a decrease in back pain.  The reports have been that these SEDMax^TM Units remove or attenuate back pain for an average of seven days after one 25-minute treatment..  Dr. Ira Fedder (Orthopaedic Surgeon) reported, "in uncontrolled trials, it is clear to me that this device has a role in the treatment of acute and chronic back pain.  Some patients are clear responders even after one 25-minute treatment and have actively tried to pursue further access to the unit." 
Our experience since late 2002 has encouraged Bio-Enhancement to promote the SEDMax^TM technology.  We have recieved positive support from health care professionals and therefore judge the market to be clinically receptive.  

Memory Function

A number of studies, from Oxford University, using the animal model, on which the rationale for our SEDMax products are based, have shown substantial increases in brain blood flow and in brain utilization of oxygen and glucose.

In virtually all subjects on whom the SEDMax products have been tested, we have observed a slight flushing of the face and hands, suggesting strongly that the same increase in blood flow observed in animal studies, is also seen in humans who use the SEDMax products.

These findings suggest that the type of stimulus employed in the SEDMax products, by increasing cerebral blood flow, may help enhance cognitive function, for example, memory, and possibly slow disease induced impairment of cognitive function.